首页> 外文期刊>Acta Poloniae Pharmaceutica: Durg Research >EFFECT OF SOLUBLISING AIDS ON THE ENTRAPMENT OF LORATIDINE IN PRE-FABRICATED PVA FILAMENTS USED FOR FDM BASED 3D-PRINTING
【24h】

EFFECT OF SOLUBLISING AIDS ON THE ENTRAPMENT OF LORATIDINE IN PRE-FABRICATED PVA FILAMENTS USED FOR FDM BASED 3D-PRINTING

机译:增溶化助剂对基于FDM基于FDM的3D印刷的预制PVA长丝中LorataDine的抑制作用

获取原文
获取原文并翻译 | 示例
           

摘要

Low drug loading efficiency is the limiting factor in the use of pre-fabricated filaments for 3D printing of pharmaceuticals. The aim of the present study was to modify the material properties of pre-fabricated filament by incorporating suitable solubilizing aids in order to enhance the drug loading efficiency. Loratadine was loaded into PVA filaments by using solubilizers (Soluplus (R), Sodium lauryl sulfate) and plasticizers (glycerin and Polyethylene glycol-400) and the printability of filaments was investigated. The treated filaments were characterized for morphology and diameter changes, drug content, FTIR and thermal properties and printed into tablets of suitable dimensions. The printed tablets were also characterized for drug assay and drug release. The results have shown that the surface of different drug-loaded filaments becomes rough with almost no change in diameter hence, these filaments remained printable. However, there was 7 to 24 times enhancement in drug content of treated filaments with particularly those pretreated with glycerin and soaked in drug solution containing Soluplus. The printed tablets have also shown almost similar drug content as their precursor filaments and the release followed diffusion mechanism in most of the formulations. The study concludes that the treatment of PVA filament with solubilizer aids has significantly improved drug loading without compromising the printability.
机译:低药物负载效率是使用预制造的长丝用于药物的3D印刷的限制因素。本研究的目的是通过掺入合适的增溶化助剂来改变预制造的长丝的材料特性,以提高药物负载效率。通过使用增溶剂(Soluplus,十二烷基硫酸钠)和增塑剂(甘油和聚乙二醇-400),将LorataDine装入PVA长丝中,研究了长丝的可印刷性。经处理的长丝的特征在于形态和直径变化,药物含量,FTIR和热性能,并印刷成适当尺寸的片剂。印刷片剂还表征了药物测定和药物释放。结果表明,不同药物负载丝的表面变得粗糙,直径几乎没有变化,这些长丝保持可印刷。然而,在预处理甘油中的预处理和含有Soluplus的药物溶液中,有7至24倍的药物含量提高了7至24倍。印刷片剂还示出了几乎与其前体细丝的药物含量几乎相似,并且在大部分制剂中释放释放释放机理。该研究的结论是,用溶解剂的PVA长丝的治疗显着提高了药物载荷而不损害可印刷性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号